SIP sigma pharmaceuticals limited

Ann: Sigma 2014/15 Full Year ASX Release, page-9

  1. 3,173 Posts.
    lightbulb Created with Sketch. 697
    Yes, it is certainly a turnaround story.

    Good to see growth in income alternatives other then the PBS.

    I was thinking they might go to a 4c divi (total), but 2c + 1c and a good turnaround story is quite compelling. (i hadn't kept track of how much sip had bought back via the SBB). They have good cashflows, the SBB continues, they are signalling ff divies in future and continuing high payout ratios.

    Agree jm69, although $1.20 might be a stretch - i expect it to continue to rerate over the next 6-12 mths to around $1 -$1.10.

    Will change my recommendation to a buy, but i'm very happy to hold and buy on this dips.

    Cheers,
    Mac



    Please dyor.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.